Following the identification of a CD4+ human ventricular cardiac fibroblast (hVCF) subpopulation in vitro using mass cytometry, we determined the clinical relevance of this population by mapping the distribution and expression of αSMA+CD4+ cells in autopsy specimens of patients diagnosed with RV fibrosis and PAH. The gene discussed is ACTA1; the disease is pulmonary arterial hypertension.